Takeda Pharmaceuticals invited banks in Japan and internationally to participate in the syndication process for Takeda's $30.85 billion loan as it prepares to purchase Shire, Bloomberg reports.
Here's what you should know.
1. The syndication allows lenders an opportunity to lend money to Takeda for the Shire purchase.
2. Bloomberg reports investing is not without risk, as Takeda had its debt rating downgraded to A2 by Moody's Investors Service earlier this month.
3. Unnamed sources report Takeda is asking lenders to commit to at least $500 million to join in the syndication.